购物车
  • 全部删除
  • TargetMol
    您的购物车当前为空

CCR6 Protein-VLP, Human, Recombinant (Flag)

产品编号 TMPY-07064

CCR6 Protein-VLP, Human, Recombinant (Flag) is expressed in HEK293 Cells. The accession number is P51684.

CCR6 Protein-VLP, Human, Recombinant (Flag)

CCR6 Protein-VLP, Human, Recombinant (Flag)

产品编号 TMPY-07064
CCR6 Protein-VLP, Human, Recombinant (Flag) is expressed in HEK293 Cells. The accession number is P51684.
规格价格库存数量
20 μg¥ 6,390期货
100 μg¥ 13,300期货
500 μg¥ 47,300期货
大包装 & 定制
加入购物车
实验操作小课堂
常见问题解答
查看更多
TargetMol 的所有产品仅用作科学研究或药证申报,不能被用于人体,我们不向个人提供产品和服务。请您遵守承诺用途,不得违反法律法规规定用于任何其他用途。

产品信息

生物活性
Immobilized CCR6 Protein-VLP, Human, Recombinant (Flag) (Cat#TMPY-07064) at 5 μg/mL (100 μL/well) can bind Anti-CCR6 Monoclonal Antibody, Human IgG1, the EC50 is 1-5 ng/mL.
产品描述
CCR6 Protein-VLP, Human, Recombinant (Flag) is expressed in HEK293 Cells. The accession number is P51684.
种属
Human
表达系统
HEK293 Cells
标签N-Flag
蛋白编号P51684
别名
STRL22,GPR-CY4,GPRCY4,GPR29,DRY-6,DRY6,DCR2,CMKBR6,CKR-L3,CKRL3,CD196,CCR-6,CC-CKR-6,C-C CKR-6,BN-1
蛋白构建
A DNA sequence encoding the Human CCR6 (P51684) (Met1-Met374) was expressed with a flag tag at the N-terminus.
分子量43.49 kDa (predicted)
内毒素< 1.0 EU per μg of the protein as determined by the LAL method
缓冲液Supplied as sterile 50 mM Hepes, 150 mM NaCl, 10% Trehalose, pH 7.2. Please contact us for any concerns or special requirements. Please refer to the specific buffer information in the hardcopy of datasheet or the lot-specific COA.
存储
Samples are stable for up to twelve months from date of receipt at -70℃. Store it under sterile conditions at -70℃ or lower. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
运输方式It is supplied and shipped as liquid with dry ice.
研究背景
Chemokine receptors CCR6 and CCR7 have been reported to play important roles in T cell migration and organ-specific metastasis of various tumors. The expression levels of CCR6 and CCR7 in tumor tissues in patients with lymph node metastases than those without lymph node metastases. CCR6 and CCR7 expressions were also detected in metastatic lymph nodes. CCR6(+) subset of CD4(+) regulatory T cells, a newly characterized subset of Tregs, has been reported to contribute to local immune inhibition. There is a new subset of tumor-resident Tregs, CCR6(+) Tregs, may be dominantly responsible for the immunosuppression in tumor immunity and a potential predictor of the poor prognosis of breast cancer.

计算器

  • 复溶 计算器
  • 重组蛋白稀释 计算器
  • 比活力 计算器

技术支持

请阅读 重组蛋白用户指南 了解更多具体信息.